EGFR and ovarian cancer: Lewis y significantly increased the proliferative capacity of ovarian cancer cells [70], which we subsequently found by activating PI3K/Akt signaling and promoting EGFR, TGF-β1, VEGF and b-FGF and other growth factors [19, 24, 26].